Compared to normal tissues, the expression level of hyaluronan in lung cancer patients is significantly upregulated, and the elevated level of hyaluronan is regulated by USP17 through deconjugating polyubiquitin chains from HAS2 [47]. This evidence concerns the gene USP17L9P and lung carcinoma.